000 | 01460 a2200445 4500 | ||
---|---|---|---|
005 | 20250514000056.0 | ||
264 | 0 | _c20010712 | |
008 | 200107s 0 0 eng d | ||
022 | _a0378-5173 | ||
024 | 7 |
_a10.1016/s0378-5173(01)00631-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKim, M K | |
245 | 0 | 0 |
_aFormulation of a reservoir-type testosterone transdermal delivery system. _h[electronic resource] |
260 |
_bInternational journal of pharmaceutics _cMay 2001 |
||
300 |
_a51-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aDelayed-Action Preparations |
650 | 0 | 4 | _aDrug Delivery Systems |
650 | 0 | 4 | _aExcipients |
650 | 0 | 4 | _aGels |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLactose _xanalogs & derivatives |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethylcellulose _xanalogs & derivatives |
650 | 0 | 4 | _aOxazines |
650 | 0 | 4 | _aRadioimmunoassay |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSkin Absorption |
650 | 0 | 4 | _aSolubility |
650 | 0 | 4 |
_aTestosterone _xadministration & dosage |
650 | 0 | 4 | _aViscosity |
700 | 1 | _aZhao, H | |
700 | 1 | _aLee, C H | |
700 | 1 | _aKim, D D | |
773 | 0 |
_tInternational journal of pharmaceutics _gvol. 219 _gno. 1-2 _gp. 51-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0378-5173(01)00631-7 _zAvailable from publisher's website |
999 |
_c11270226 _d11270226 |